Butalbital/aspirin/caffeine/codeine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
'''''For patient information about Butalbital/aspirin/caffeine/codeine, click [[Butalbital/aspirin/caffeine/codeine (patient information)|here]].''''' | '''''For patient information about Butalbital/aspirin/caffeine/codeine, click [[Butalbital/aspirin/caffeine/codeine (patient information)|here]].''''' | ||
{{SB}} ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule | {{SB}} ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule<sup>®</sup> | ||
==Overview== | ==Overview== | ||
| Line 31: | Line 31: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ASCOMP WITH CODEINE (BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE) CAPSULE [NEXGEN PHARMA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca3fe6e9-21ad-4fba-a602-e1c364cf3981 | publisher = | date = | accessdate = }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ASCOMP WITH CODEINE (BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE) CAPSULE [NEXGEN PHARMA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca3fe6e9-21ad-4fba-a602-e1c364cf3981 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 23:39, 11 February 2014
| Butalbital/aspirin/caffeine/codeine |
|---|
| ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital, aspirin, cafeine, and codeine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Butalbital/aspirin/caffeine/codeine, click here.
Synonyms / Brand Names: ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule®
Overview
Category
FDA Package Insert
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages